Market Overview:Thromboelastography is a diagnostic method used to assess a patient's blood coagulation function in real-time. It measures a patient's blood clot formation and dissolution, providing valuable information about the patient's overall clotting ability. Thromboelastography is widely used in medical practices, particularly in surgeries and critical care settings, to monitor and...
The global Thromboelastography Market is estimated to be valued at US$ 125.17 Bn in 2023 and is expected to exhibit a CAGR of 7.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
SWOT Analysis:-
· Strengths: TEG provides real-time evaluation of hemostasis and helps in effective...
Market Dynamics:The Thromboelastography Market is primarily driven by increasing prevalence of coagulation disorders. For instance, according to data published by National Hemophilia Foundation, hemophilia affects approximately 20,000 males in the United States. Thromboelastography is extensively used for diagnosing and monitoring coagulation profiles in hemophilia patients. Additionally,...
The Thromboelastography Market is estimated to be valued at US$ 604.07 Mn in 2022 and is expected to exhibit a CAGR of 7.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview:Thromboelastography (TEG) is increasingly being used in clinical practice for hemostasis testing and monitoring. It provides insights into the...
Thromboelastography (TEG®) is a point-of-care testing method that provides a comprehensive analysis of a patient's hemostatic system including fibrinolysis. TEG® provides crucial information to guide transfusion and hemostatic therapy in complex cases. This article will discuss what TEG® is, how it works, its clinical applications and the benefits it provides over standard...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Romaian